These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 30651044)

  • 1. Preparing regenerative therapies for clinical application: proposals for responsible translation.
    Shapiro SA; Smith CG; Arthurs JR; Master Z
    Regen Med; 2019 Feb; 14(2):77-84. PubMed ID: 30651044
    [No Abstract]   [Full Text] [Related]  

  • 2. Institutional profile. The International Society for Cellular Therapy: evolving to meet the demands of the regenerative medicine industry.
    Maziarz RT; Arthurs J; Horwitz E
    Regen Med; 2011 Mar; 6(2):163-6. PubMed ID: 21391849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regenerative medicine: future impact on clinical therapies and society.
    Kargul J; Laurent GJ; Irminger-Finger I
    Int J Biochem Cell Biol; 2014 Nov; 56():1. PubMed ID: 25461768
    [No Abstract]   [Full Text] [Related]  

  • 4. Photobiomodulation Therapy of Cells in the Bone Marrow: A Novel Therapeutic Approach in Cell Therapy and Regenerative Medicine.
    Oron U
    Photobiomodul Photomed Laser Surg; 2019 Jan; 37(1):1-3. PubMed ID: 31050935
    [No Abstract]   [Full Text] [Related]  

  • 5. Bridging stem cell research and medicine: a learning health system.
    Touré SB; Kleiderman E; Knoppers BM
    Regen Med; 2018 Sep; 13(6):741-752. PubMed ID: 30043682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging Translation of Regenerative Therapies.
    Allickson JG
    Clin Pharmacol Ther; 2017 Jan; 101(1):28-30. PubMed ID: 27806427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-based therapies for the preterm infant.
    Zhu D; Wallace EM; Lim R
    Cytotherapy; 2014 Dec; 16(12):1614-28. PubMed ID: 25154811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Youthful prospects for human stem-cell therapy. In another few decades, revised attitudes toward stem cells could lead to disease prevention and life extension.
    Rosenthal N
    EMBO Rep; 2005 Jul; 6 Spec No(Suppl 1):S30-4. PubMed ID: 15995658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current status and perspective on regenerative medicine for spinal cord injury using iPS cell].
    Nakamura M; Toyama Y; Okano H
    Rinsho Shinkeigaku; 2013; 53(11):1013-5. PubMed ID: 24291863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Regenerative therapy for post-stroke patients].
    Yamashita T; Abe K
    Nihon Rinsho; 2016 Apr; 74(4):661-5. PubMed ID: 27333756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of bone marrow-derived cells for regenerative medicine in Cuba.
    Hernández P
    Bone Marrow Transplant; 2016 Jan; 51(1):134. PubMed ID: 26367216
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutic potential of human adipose-derived stem cells in neurological disorders.
    Chang KA; Lee JH; Suh YH
    J Pharmacol Sci; 2014; 126(4):293-301. PubMed ID: 25409785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational Strategies for Niche-Dependent Cell Conversion to Assist Stem Cell Therapy.
    Del Sol A; Okawa S; Ravichandran S
    Trends Biotechnol; 2019 Jul; 37(7):687-696. PubMed ID: 30782480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Science-based assessment of source materials for cell-based medicines: report of a stakeholders workshop.
    Stacey G; Andrews P; Asante C; Barbaric I; Barry J; Bisset L; Braybrook J; Buckle R; Chandra A; Coffey P; Crouch S; Driver P; Evans A; Gardner J; Ginty P; Goldring C; Hay DC; Healy L; Hows A; Hutchinson C; Jesson H; Kalber T; Kimber S; Leathers R; Moyle S; Murray T; Neale M; Pan D; Park BK; Rebolledo RE; Rees I; Rivolta MN; Ritchie A; Roos EJ; Saeb-Parsy K; Schröder B; Sebastian S; Thomas A; Thomas RJ; Turner M; Vallier L; Vitillo L; Webster A; Williams D
    Regen Med; 2018 Dec; 13(8):935-944. PubMed ID: 30488776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of Regenerative Medicine Products.
    Gee AP
    Adv Exp Med Biol; 2018; 1098():189-198. PubMed ID: 30238372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The advancement of human pluripotent stem cell-derived therapies into the clinic.
    Thies RS; Murry CE
    Development; 2015 Sep; 142(18):3077-84. PubMed ID: 26395136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Component therapy to cellular therapy and beyond- a Darwinian approach to transfusion medicine.
    Snyder EL
    Transfusion; 2008 Sep; 48(9):2000-7. PubMed ID: 18694467
    [No Abstract]   [Full Text] [Related]  

  • 18. Stem cell-based treatment of kidney diseases.
    Pan B; Fan G
    Exp Biol Med (Maywood); 2020 May; 245(10):902-910. PubMed ID: 32281411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of Cellular and Tissue-based Products for Retinal Regenerative Medicine].
    Osakada F
    Yakugaku Zasshi; 2017; 137(1):23-29. PubMed ID: 28049891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organ Chips: Quality Assurance Systems in Regenerative Medicine.
    Pasqualini FS; Emmert MY; Parker KK; Hoerstrup SP
    Clin Pharmacol Ther; 2017 Jan; 101(1):31-34. PubMed ID: 27709615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.